Skip to content
value.today

Rennova Health, Inc.

Total raised
$111 M
21 rounds on record
Latest round
$2 M
Mar 2022
First round on record
Nov 2015
Today
Private
No later event on record

Funding rounds

21 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Rennova Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2022$2 MNo. 21Under $2 million

Rennova Health, Inc.: Raise no. 21, Mar 2022

Investors in this round

2 investors had bought by the notice of Apr 7, 2022: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Seamus Lagan · Executive Officer, Director
  • Gary Blum · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Apr 7, 2022 (1 amendment). Read the notice at the SEC.

equity, optionsSEC
Oct 2021$4 MNo. 20$2 to $10 million

Rennova Health, Inc.: Raise no. 20, Oct 2021

Investors in this round

2 investors had bought by the notice of Dec 17, 2021: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Seamus Lagan · Executive Officer, Director
  • Gary Blum · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Dec 17, 2021 (1 amendment). Read the notice at the SEC.

equity, optionsSEC
Sep 2021$1 MNo. 19Under $2 million

Rennova Health, Inc.: Raise no. 19, Sep 2021

Investors in this round

2 investors had bought by the notice of Oct 4, 2021: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Seamus Lagan · Executive Officer, Director
  • Gary Blum · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Oct 4, 2021. Read the notice at the SEC.

equity, optionsSEC
May 2021$4 MNo. 18$2 to $10 million

Rennova Health, Inc.: Raise no. 18, May 2021

Investors in this round

2 investors had bought by the notice of Aug 13, 2021: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Seamus Lagan · Executive Officer, Director
  • Gary Blum · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Aug 13, 2021 (3 amendments). Read the notice at the SEC.

equity, optionsSEC
Aug 2020$30 MNo. 17$10 to $50 million

Rennova Health, Inc.: Raise no. 17, Aug 2020

Investors in this round

2 investors had bought by the notice of Sep 3, 2020: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$30 M of $30 M offered
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Seamus Lagan · Executive Officer, Director
  • Gary L. Blum · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Sep 3, 2020. Read the notice at the SEC.

equity, optionsSEC
Jun 2020$19 MNo. 16$10 to $50 million

Rennova Health, Inc.: Raise no. 16, Jun 2020

Investors in this round

1 investor had bought by the notice of Jul 13, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$19 M of $19 M offered
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Seamus Lagan · Executive Officer, Director
  • Gary L. Blum · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Jul 13, 2020. Read the notice at the SEC.

equity, optionsSEC
Nov 2018$1 MNo. 15Under $2 million

Rennova Health, Inc.: Raise no. 15, Nov 2018

Investors in this round

2 investors had bought by the notice of Nov 26, 2018: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Marlene L. McLennan · Executive Officer
  • Seamus Lagan · Executive Officer, Director
  • Christopher Diamantis · Director
  • Gary L. Blum · Director
  • John Beach · Director
  • Kamran Ajami · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Nov 26, 2018. Read the notice at the SEC.

debt, optionsSEC
Sep 2018$1 MNo. 14Under $2 million

Rennova Health, Inc.: Raise no. 14, Sep 2018

Investors in this round

2 investors had bought by the notice of Sep 13, 2018: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Marlene L. McLennan · Executive Officer
  • Seamus Lagan · Executive Officer, Director
  • Christopher Diamantis · Director
  • Gary L. Blum · Director
  • John Beach · Director
  • Kamran Ajami · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Sep 13, 2018. Read the notice at the SEC.

debt, optionsSEC
Aug 2018$1 MNo. 13Under $2 million

Rennova Health, Inc.: Raise no. 13, Aug 2018

Investors in this round

2 investors had bought by the notice of Aug 7, 2018: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Marlene L. McLennan · Executive Officer
  • Seamus Lagan · Executive Officer, Director
  • Christopher Diamantis · Director
  • Gary L. Blum · Director
  • John Beach · Director
  • Kamran Ajami · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Aug 7, 2018. Read the notice at the SEC.

debt, optionsSEC
Jul 2018$1 MNo. 12Under $2 million

Rennova Health, Inc.: Raise no. 12, Jul 2018

Investors in this round

2 investors had bought by the notice of Jul 17, 2018: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Seamus Lagan · Executive Officer, Director
  • Christopher Diamantis · Director
  • Gary L. Blum · Director
  • John Beach · Director
  • Kamran Ajami · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Jul 17, 2018. Read the notice at the SEC.

debt, optionsSEC
May 2018$1 MNo. 11Under $2 million

Rennova Health, Inc.: Raise no. 11, May 2018

Investors in this round

2 investors had bought by the notice of May 16, 2018: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Seamus Lagan · Executive Officer, Director
  • Christopher Diamantis · Director
  • Gary L. Blum · Director
  • John Beach · Director
  • Kamran Ajami · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed May 16, 2018. Read the notice at the SEC.

debt, optionsSEC
Mar 2018$2 MNo. 10$2 to $10 million

Rennova Health, Inc.: Raise no. 10, Mar 2018

Investors in this round

2 investors had bought by the notice of Mar 8, 2018: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Seamus Lagan · Executive Officer, Director
  • Christopher Diamantis · Director
  • Gary L. Blum · Director
  • John Beach · Director
  • Kamran Ajami · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Mar 8, 2018. Read the notice at the SEC.

debt, optionsSEC
Oct 2017$4 MNo. 9$2 to $10 million

Rennova Health, Inc.: Raise no. 9, Oct 2017

Investors in this round

2 investors had bought by the notice of Nov 8, 2017: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Seamus Lagan · Executive Officer, Director
  • Christopher Diamantis · Director
  • Gary L. Blum · Director
  • John Beach · Director
  • Kamran Ajami · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Nov 8, 2017. Read the notice at the SEC.

equity, optionsSEC
Sep 2017$2 MNo. 8Under $2 million

Rennova Health, Inc.: Raise no. 8, Sep 2017

Investors in this round

8 investors had bought by the notice of Oct 10, 2017: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Pollack · Executive Officer · Interim Chief Financial Officer
  • Seamus Lagan · Executive Officer, Director
  • Christopher Diamantis · Director
  • Kamran Ajami · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Oct 10, 2017. Read the notice at the SEC.

equity, optionsSEC
Sep 2017$9 MNo. 7$2 to $10 million

Rennova Health, Inc.: Raise no. 7, Sep 2017

Investors in this round

2 investors had bought by the notice of Sep 26, 2017: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Pollack · Executive Officer · Interim Chief Financial Officer
  • Seamus Lagan · Executive Officer, Director
  • Christopher Diamantis · Director
  • Kamran Ajami · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Sep 26, 2017. Read the notice at the SEC.

debt, optionsSEC
Jul 2017$4 MNo. 6$2 to $10 million

Rennova Health, Inc.: Raise no. 6, Jul 2017

Investors in this round

2 investors had bought by the notice of Jul 20, 2017: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Pollack · Executive Officer · Interim Chief Financial Officer
  • Seamus Lagan · Executive Officer, Director
  • Christopher Diamantis · Director
  • Kamran Ajami · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Jul 20, 2017. Read the notice at the SEC.

debt, optionsSEC
Jun 2017$2 MNo. 5Under $2 million

Rennova Health, Inc.: Raise no. 5, Jun 2017

Investors in this round

2 investors had bought by the notice of Jun 26, 2017: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Pollack · Executive Officer · Interim Chief Financial Officer
  • Seamus Lagan · Executive Officer, Director
  • Christopher Diamantis · Director
  • Kamran Ajami · Director
  • Trevor Langley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Jun 26, 2017. Read the notice at the SEC.

debt, optionsSEC
Mar 2017$16 MNo. 4$10 to $50 million

Rennova Health, Inc.: Raise no. 4, Mar 2017

Investors in this round

4 investors had bought by the notice of Apr 3, 2017: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$16 M of $16 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$262,500
Finders' fees
none
Paid to its own people
$3,833,160 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Seamus Lagan · Executive Officer, Director
  • Christopher Diamantis · Director
  • Michael L Goldberg · Director
  • Paul Billings · Director
  • Robert L Lee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Aegis Capital Corp. (CRD 15007) · New York, New YorkSold in all US states

Signed by Seamus Lagan, Chief Executive Officer. Newest notice filed Apr 3, 2017. Read the notice at the SEC.

debt, optionsSEC
Feb 2017$2 MNo. 3Under $2 million

Rennova Health, Inc.: Raise no. 3, Feb 2017

Investors in this round

4 investors had bought by the notice of Feb 2, 2017: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$1
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Seamus Lagan · Executive Officer, Director
  • Christopher Diamantis · Director
  • Michael L Goldberg · Director
  • Paul Billings · Director
  • Robert L Lee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Seamus Lagan, Chief Executive Officer and President. Newest notice filed Feb 2, 2017. Read the notice at the SEC.

debt, optionsSEC
Aug 2016$1 MNo. 2Under $2 million

Rennova Health, Inc.: Raise no. 2, Aug 2016

Investors in this round

4 investors had bought by the notice of Aug 12, 2016: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$1
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jason P Adams · Executive Officer
  • Seamus Lagan · Executive Officer, Director
  • Thomas R Mika · Executive Officer, Director
  • Benjamin R Frank · Director
  • Christopher R Diamantis · Director
  • Michael L Goldberg · Director
  • Paul R Billings · Director
  • Robert L Lee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Shares of common stock and warrants are being issued in consideration of cancellation of certain indebtedness and other obligations, including fees and expenses. No gross proceeds will be received upon the issuance of the shares of stock or warrants.”

Signed by Seamus Lagan, Chief Executive Officer and President. Newest notice filed Aug 12, 2016. Read the notice at the SEC.

equity, optionsSEC
Nov 2015$2 MNo. 1$2 to $10 million

Rennova Health, Inc.: Raise no. 1, Nov 2015

Investors in this round

9 investors had bought by the notice of Nov 16, 2015: 1 accredited, 8 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Rennova Health, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$1
What was sold
options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jason P Adams · Executive Officer
  • Samuel R Mitchell · Executive Officer
  • Seamus Lagan · Executive Officer, Director
  • Thomas R Mika · Executive Officer, Director
  • Benjamin R Frank · Director
  • Christopher R Diamantis · Director
  • Michael L Goldberg · Director
  • Paul R Billings · Director
  • Robert L Lee · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Offering amount is calculated based on the exercise price of the options being granted.”
  • On the use of proceeds: “No gross proceeds will be received upon the grant of the options.”

Signed by Seamus Lagan, Chief Executive Officer and President. Newest notice filed Nov 16, 2015. Read the notice at the SEC.

optionsSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Rennova Health, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2022).

    SEC Form D · Apr 2022

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Apr 2022

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

7 named in official filings. Open an investor to see everything it has backed.

Investors in Rennova Health, Inc.
InvestorKindAmountRoundRoleSource
Aella, Ltd.Companynot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2016)SEC Form 3
Epizon Ltd.Companynot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2016)SEC Form 3
Francisco Roca IIIPersonnot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Steven SramowiczPersonnot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2016)SEC Form 3
The Olive Tree TrustOthernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2016)SEC Form 3
The Shanovan TrustOthernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2016)SEC Form 3
Thomas Francis Do MendoliaPersonnot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2015)SEC Form 3

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Rennova Health, Inc.
NameRoleNamed in
Seamus LaganExecutive officerApr 2022
Marlene L. McLennanExecutive officerNov 2018
Michael PollackInterim Chief Financial OfficerOct 2017
Jason P AdamsExecutive officerAug 2016
Thomas R MikaExecutive officerAug 2016
Samuel R MitchellExecutive officerNov 2015
Gary BlumDirectorApr 2022
Seamus LaganDirectorApr 2022
Trevor LangleyDirectorApr 2022
Gary L. BlumDirectorSep 2020
Christopher DiamantisDirectorNov 2018
John BeachDirectorNov 2018
Kamran AjamiDirectorNov 2018
Michael L GoldbergDirectorApr 2017
Paul BillingsDirectorApr 2017
Robert L LeeDirectorApr 2017
Benjamin R FrankDirectorAug 2016
Christopher R DiamantisDirectorAug 2016
Paul R BillingsDirectorAug 2016
Thomas R MikaDirectorAug 2016